Related Experiment Video

Updated: Jun 19, 2026

Identification of Functionally-Relevant Lentivirus Integration Sites in an Insertional Mutagenesis Cell Library
07:28

Identification of Functionally-Relevant Lentivirus Integration Sites in an Insertional Mutagenesis Cell Library

Published on: January 10, 2025

Identification of protein tyrosine kinases with oncogenic potential using a retroviral insertion mutagenesis screen

Els Lierman1, Helen Van Miegroet, Els Beullens

  • 1Department of Molecular and Developmental Genetics, VIB, Leuven, Belgium.

Haematologica
|October 2, 2009
PubMed

Insights

This study identified protein tyrosine kinases that drive cancer by enabling hematopoietic cells to grow uncontrollably. The research utilized a novel retroviral insertion screen to discover these potential oncogenes.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Signaling

Background:

  • Protein tyrosine kinases are crucial signaling proteins involved in normal and cancerous cell functions.
  • Constitutive activation of these kinases can lead to uncontrolled cell proliferation, a hallmark of cancer.

Purpose of the Study:

  • To identify protein tyrosine kinases capable of transforming hematopoietic cells into a state of growth factor-independent proliferation.
  • To investigate the role of constitutive activation via homodimerization in kinase-driven transformation.

Main Methods:

  • A modified retroviral insertion mutagenesis screen was employed.
  • A retroviral vector encoding the ETV6 homodimerization domain and an artificial splice donor site was utilized.
  • The Ba/F3 cell line, dependent on IL3 for survival, was used to screen for transforming kinases.

Main Results:

  • Eight protein tyrosine kinases (Abl1, Fgfr1, Hck, Jak2, Lck, Mertk, Mst1r, Tnk1) were identified as capable of transforming Ba/F3 cells.
  • HCK, MERTK, MST1R, and TNK1 were characterized as potential oncogenes.
  • The retroviral insertion screen successfully identified gain-of-function fusion genes.

Conclusions:

  • Constitutive activation of specific protein tyrosine kinases through homodimerization can drive oncogenesis.
  • The developed retroviral insertion screening method is effective for identifying novel oncogenic fusion genes.
  • HCK, MERTK, MST1R, and TNK1 represent promising targets for cancer research and therapeutic development.

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.